ZhongRong And Aier Set Up Joint M&A Fund For China Health Care
This article was originally published in PharmAsia News
Executive Summary
ZhongRong KangJian Venture and Aier Medical Investment have set up a joint M&A fund of up to RMB 1 billion ($162 million) aimed at the health care industry and asset restructuring at public medical institutes.